TORONTO (Reuters) - Tekmira Pharmaceuticals Corp will supply one of its experimental Ebola treatments for clinical studies to be conducted in West Africa by a consortium that includes England's Oxford university, the Canadian company said on Monday. Tekmira said 100 courses of its TKM-Ebola-Guinea treatment will be made available for the studies, and that it has entered into a manufacturing and clinical trial agreement with Oxford. ...
via Health News Headlines - Yahoo News
Read More Here.. 
Lake forest health and fitness http://ift.tt/1zbWfWM
No comments:
Post a Comment